Grant: CIHR-ICRH Travel Awards - General pool
University of Ottawa
$1,500.00
Impact of age and sex on TAVR adoption and outcomes in France
FY 2023-24
Summary
Aortic stenosis is a degenerative disease of the aortic valve with aortic valve replacement (AVR) being the only treatment option. Transcatheter aortic valve replacement (TAVR) is an alternative to open heart srugery. As technology has improved, surgical vs transcatheter trends according to age and sex remain unknown. Using French AVR registry data, TAVR has become the predominant modality in older patients but seldom utilized in patients <65 years, reserved for high surgical risk patients. Women are older with fewer co-morbidities and more frequently undergo TAVR, yet experience higher in-hospital mortality than men.
Department
Program
CIHR-ICRH Travel Awards - General pool
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
495294
Name
Prosperi-Porta Graeme
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Prcname2
Special Cases
Projecttitle
Impact of age and sex on TAVR adoption and outcomes in France
Programtype2
Undefined
Orgnameinp2
University of Ottawa
Cihramount2
$1,500
Cihrequipment2
$0
Programname2
CIHR-ICRH Travel Awards - General pool
Keyworddelim
Aortic Stenosis
Abstract
Aortic stenosis is a degenerative disease of the aortic valve with aortic valve replacement (AVR) being the only treatment option. Transcatheter aortic valve replacement (TAVR) is an alternative to open heart srugery. As technology has improved, surgical vs transcatheter trends according to age and sex remain unknown. Using French AVR registry data, TAVR has become the predominant modality in older patients but seldom utilized in patients <65 years, reserved for high surgical risk patients. Women are older with fewer co-morbidities and more frequently undergo TAVR, yet experience higher in-hospital mortality than men.
Competitiondate
202309
Approvedterm2
1 yr 0 mth
Pinamesdelim
Prosperi-Porta, Graeme
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $1,500~ $0~
